VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,916 | -16.1% | 8,395 | -6.2% | 0.06% | -11.3% |
| Q2 2023 | $269,371 | -17.9% | 8,946 | -11.7% | 0.07% | -22.0% |
| Q1 2023 | $327,936 | +29.2% | 10,137 | +14.5% | 0.09% | +23.0% |
| Q4 2022 | $253,853 | +15.9% | 8,857 | -2.4% | 0.07% | +5.7% |
| Q3 2022 | $219,000 | -11.7% | 9,076 | +0.4% | 0.07% | -4.1% |
| Q2 2022 | $248,000 | -28.5% | 9,040 | 0.0% | 0.07% | -19.8% |
| Q1 2022 | $347,000 | +19.7% | 9,040 | 0.0% | 0.09% | +21.3% |
| Q4 2021 | $290,000 | +22.4% | 9,040 | +25.5% | 0.08% | +21.0% |
| Q3 2021 | $237,000 | -3.3% | 7,202 | 0.0% | 0.06% | -7.5% |
| Q2 2021 | $245,000 | +4.7% | 7,202 | 0.0% | 0.07% | -1.5% |
| Q1 2021 | $234,000 | +8.3% | 7,202 | +15.1% | 0.07% | +6.2% |
| Q4 2020 | $216,000 | – | 6,259 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |